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Introduction 
 Emergence of nosocomial bacterial pathogens 
(especially Gram-negative bacteria) with multiple 
resistance against almost all available antibiotics is a 
growing medical problem [1, 2]. No novel drugs targeting 
multidrug-resistant Gram-negative bacteria have been 
developed in recent years [3, 4]. In this context, there has 
been greatly renewed interest to cyclic lipodecapeptides 
polymyxins [5-7]. Polymyxins exhibit rapid bactericidal 
activity [8]. They are specific and highly potent against 
Gram-negative bacteria [9], but have potential nephrotoxic 
side effects [7]. So polymyxins are attractive lead 
compounds to develop analogues with improved 
microbiological, pharmacological and toxicological 
properties [5, 10, 11]. A detailed knowledge on the 
molecular mechanisms of polymyxin interactions with its 
cell targets is a prerequisite for the purposeful 
improvement of its therapeutic properties.  Polymyxin B3 
(PmB3) consists of a cyclic heptapeptide ring, together with 
a tripeptide side chain that is attached to an octanoyl fatty 
acyl chain (Fig. 1). PmB3 contains six L-α,γ-
diaminobutyric acid (Dab) residues, five of which are 
positively charged under physiological conditions. The 
primary cell target of a polymyxin is a lipopolysaccharide 
(LPS) in the outer membrane of Gram-negative bacteria 
[12]. Typical LPS molecule is a complex biopolymer 
composed of three major structural fragments: a variable 
outer oligosaccharade (or O-antigen), a core 
oligosaccharide region (both composed of repeating units 
of various polysaccharides) and the conserved lipid A 
portion [13]. Lipid A anchors the LPS molecule to the outer 
membrane. The “classic” E. coli lipid A consists of two 
glucosamines (GlcN I and GlcN II), two phosphate esters 
and six fatty acid chains (M, L, HM1-4) (Fig. 2). Lipid A 
is linked to the core oligosaccharide region by two 2-keto-
3-deoxyoctanate (Kdo2) residues [13]. The structure of 
LPS and its interactions with a binding peptide have been 
revealed in the single case of the X-ray structure of LPS in 
complex with the integral outer membrane protein FhuA 
from E. coli K-12 [14]. Amongst the most favorable 
interactions, a subset of four positively charged residues of 
FhuA has been identified. Three of these four residues 
formed strong hydrogen bonds with the phosphates of lipid 
A [14]. Structural scaffold of the four-residue motif 
appeared to be common to proteins which specifically bind 
LPS with high affinity: bactericidal/permeability-
increasing protein BPI, lactoferrin, lysozyme, Limuilus 
anti-LPS factor LALF as well as polymyxin B [14-16]. 
Solution structure of PmB as well as structural aspects of 
PmB-LPS binding have been studied by NMR techniques 
combined with molecular docking and molecular dynamics 
simulations and the models of  PmB-LPS  complex have 
been proposed [16-20]. The binding site of polymyxin on 
LPS has been supposed to be Kdo2-lipid A fragment (Fig. 
1B). In polymyxin B, the LPS-binding motif has been 
found to comprise Dab1, Dab5, Dab8 and Dab9 residues 
but their individual roles and relative contribution to the 
binding with LPS have not been established] [16-18]. 
 
 
Fig. 1. Chemical structures of polymyxin B3 (PmB3).  
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Fig. 2. Chemical structures of lipid A from E. coli K12 (Kdo2-lipid А). 
M – myristoyl, HM1-4 – hydroxymyristoyl, L – lauroyl. 
 
Recently, a series of PmB3 alanine scanning analogues was 
experimentally examined to determine the contribution of 
each amino acid position to LPS binding and antimicrobial 
activity [21]. All Ala-substituted analogues for Dab side 
chains showed greatly reduced binding affinity indicating 
an important role of Dab side residues in polymyxin-LPS 
binding. However, the binding energetics and details of 
intermolecular interactions in the complexes remained 
beyond the scope of the study.  
 In this paper, the molecular aspects of PmB3-LPS 
binding and its energetics were studied in more detail by 
molecular dynamics. Understanding the peculiarities of 
molecular interactions of polymyxins with its primary 
target on the outer membrane of Gram-negative bacteria 
may assist in the designing of novel polymyxin-like 
lipopeptides.   
 
Materials and methods 
 All computations were performed in YASARA 
[22]. Initial structures. Coordinates of polymyxin B3 were 
taken from NMR solution structure of polymyxin B1 when 
bound to E. coli LPS [17]. The coordinates of the lipid A 
portion of LPS (including two 2-keto-3-deoxyoctanate 
(Kdo) residues) were derived from the X-ray 
crystallographic  structure of LPS in complex with the 
integral outer membrane protein FhuA from  E. сoli K-12 
(1QFF) [14]. PmB3 was manually docked onto the Kdo2-
lipid A to reproduce as close as possible the structure of 
complex PmB-LPS from NMR solution experiment [17, 
18]. Then the complex was energy-minimized in a periodic 
simulation cell filled with TIP3P water molecules. The 
simulation cell was 1 nm larger than the complex along all 
three axes. Na+ and Cl¯ counterions were added to 
neutralize the system and to reach ion mass fraction 0.9% 
NaCl [23]. The AMBER03 force field [24] was used with 
a 1.05 nm force cutoff. To treat longrange electrostatic 
interactions the Particle Mesh Ewald algorithm [25] was 
used. After a short steepest descent minimization, the 
procedure continued by simulated annealing minimization 
started at 298 K, velocities were scaled down by 0.9 every 
10th step until the energy improved by less than 0.05 
kJ/mol per atom during 200 steps.  
 Local docking. The further refinement of PmB3 
location on LPS was carried out by local docking by means 
of AutoDock Vina program with standard parameters [26]. 
The above optimized PmB-LPS complex was placed in the 
center of 0.9x0.9x0.9 nm simulation cell. The structures of  
Kdo2-lipid A and PmB3 were kept rigid whereas  
polymyxin’s residues Dab 1, Dab 3, Dab 5, Dab 8 та Dab 
9 were flexible.  The output structure of the complex was 
used as a starting point for alanine scanning procedure as 
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well as for molecular dynamics simulations of PmB3–LPS 
complex.  
 Alanine scanning. The complex of PmB3 with 
Kdo2-lipid A was firstly minimized as described above. 
The water molecules located at a distance more than 0.6 
nm from the complex were deleted and the system was 
energy-minimized again. Then water shell was temporarily 
removed from the cell. All atoms of the complex with a 
distance more than 0.8 nm from the center of polymyxin 
residue to be mutated were fixed. Dab side residues of 
PmB3 were consequentially substituted by alanine and the 
water shell was added again. Water molecules with 
distance less than 0.3 nm from new mutant were deleted. 
Environment of the mutated residue was energy-
minimized. Then all water molecules were deleted and 
potential and solvation energies of the complex, the 
receptor (Kdo2-lipid A) and the ligand (PmB3) were 
calculated.  
 Molecular dynamics. The complexes of PmB3 or 
its Ala-mutants with Kdo2-lipid were placed in a periodic 
simulation cell which was filled with TIP3P water 
molecules. The systems were minimized as described 
above. The simulation cell was 1 nm larger than the 
complex along all three axes. Na+ and Cl¯ counterions 
were added to neutralize the system and to reach ion mass 
fraction 0.9% NaCl [23]. The AMBER03 force field [24] 
was used with a 1.05 nm force cutoff. The solute charges 
were assigned based on the AMBER03 force field [24], 
using GAFF/AM1BCC [27, 28] for the LPS fragment and 
N-terminal fatty acyl chain of polymyxin B3. To treat 
longrange electrostatic interactions the Particle Mesh 
Ewald algorithm [25] was used. The molecular dynamics 
simulations were run in NPT ensemble at 300 K  and pH 
7.0 using a multiple time-step of 1.25 fs for intra-molecular 
and 2.5 fs for inter-molecular forces. The Root Mean 
Square Deviations (RMSD), Root Mean Square 
Fluctuations (RMSF), mean hydrogen bond lengths and the 
H-bond probabilities were calculated by the use of macros 
md_analyze. 
 Binding energy. Binding energy was calculated as 
a difference of potential and solvation energies for ligand 
and receptor in the bound (in the complex) and in the 
unbound states (at infinite distance). Solvation energy 
included Van der Waals and Coulomb energies of 
interactions between the solute and solvent molecules. The 
entropic component of the solvation energy was 
approximated by an entropic term proportional to the 
solvent accessible surface area. The solvation energy was 
calculated using the boundary element method 
implemented in YASARA. The boundary between solvent 
(dielectric constant 78) and solute (dielectric constant 1) 
was formed by the solute molecular surface, constructed 
with a solvent probe radius of 1.4 Å. 
 
Results and discussion 
 The complex of native polymyxin B3 with 
lipopolysaccharide obtained as a result of the docking is 
presented in fig. 3. It was this structure of the complex that 
served as a starting point for an Ala-scanning as well as a 
reference structure for the subsequent comparative analysis 





Fig. 3. PmB3–LPS complex. PmB3 is depicted as a combined tube and stick model for peptide backbone and side 
chains, correspondingly. Regions of polymyxin’s turn-like secondary structure are green colored.  LPS is 
shown as a space-filling model, its molecular surface, excluding PO4 phosphate groups, is colored in light-
green. 
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 To analyze at atomic level the structural 
consequence of Ala1, Ala3, Ala5, Ala8 and Ala9 mutations 
in PmB3–LPS complex and their influence on the 
binding energetics of the complexes molecular dynamic 
simulations of these systems were carried out in water 
solution at physiological conditions.  
 Values of root mean square deviations of 
backbone Сα atoms (RMSD Сα) of polymyxin and its 
derivatives in dependence on the simulation time are 
shown in fig. 4. The values of RMSD Сα characterize a 
structure stability and a simulation integrity. For the 
complex of unmodified PmB3 with LPS, there were 
observed insignificant fluctuations of RMSD Сα near the 
mean value (after 8 ns) being the minimal amongst all 
complexes studied (fig. 4). For Ala-mutants, in contrast to 
unmodified PmB3, RMSDs of Сα atoms showed 
continuous increase and/or irregular fluctuations with large 
amplitude, revealing sustained changes in their structures 
and resulting in the less close contacts within the complex, 
the increase of the values of binding energies (fig. 5) and 
as a consequence the notable loss in stability of Ala-




       
 
 
Fig. 4. RMSD of Сα atoms from initial structures of the complexes of PmB3 and its Ala-mutants with LPS: 0 – 






Fig. 5. Binding energies of the complexes of PmB3 and its Ala-mutants with LPS: 0 – PmB3; 1 – Ala1-PmB3; 3 – 
Ala3-PmB3; 5 – Ala5-PmB3; 8 – Ala8-PmB3 and 9 – Ala9-PmB3. 
  
Annals of Mechnikov Institute, N 4, 2015 
www.imiamn.org.ua /journal.htm                                                               14 
 Amino acid residues of PmB3 bound to LPS 
showed quite predictably considerable reduction in 
mobility compared to the free peptide (red solid line versus 
red dashed line in fig. 6). Especially it concerns the 
residues that comprise LPS-binding motif: values of RMSF 




Fig. 6. RMSF of amino acid residues of PmB3 and its Ala-mutants in complex with LPS: 0 – PmB3; 1 – Ala1-
PmB3; 3 – Ala3-PmB3; 5 – Ala5-PmB3; 8 – Ala8-PmB3 and 9 – Ala9-PmB3. 
 In PmB3-LPS complex, Ala-mutations disturb the 
characteristic H-bond network not only near the mutatated 
residue but within the entire interface of the complex.
  As can be seen from table 1, where the H-bonds 
formed in complexes of PmB3 and its Ala-mutants with 
LPS as well as their parameters (mean “donor...acceptor of 
H-bond” inter-atomic distances and H-bond  
 
 
Table 1. Hydrogen bonds in complexes of PmB3 and its Ala-mutants with LPS 
Hydrogen bonds Distance N···O, Å Probability 
PmB3   
Dab1-NH···O3-P 2.933 0.522 
Dab1-NH···O4-P 3.116 0.336 
Dab8-NH···O1-HM4 3.058 0.795 
Dab9-NH···O3-P 3.015 0.117 
Dab9-NH···O4-P 2.822 0.785 
Dab9-NH···O1B-KdoII 3.292 0.700 
Ala1-PmB3   
Dab5-NH···O2-P 3.018 0.572 
Dab8-NH···O4-P 2.895 0.466 
Dab9-NH···O1A-KdoII 3.047 0.596 
Ala3-PmB3    
Dab1-NH···O4-P 2.749 0.917 
Dab8-NH···O1-HM4 2.901 0.707 
Dab9-NH···O3-P 2.737 0.953 
Thr10-OH···O8-KdoI 3.005 0.764 
Ala5-PmB3    
Dab1-NH···O3-P 2.759 0.868 
Dab9-NH···O2-P 2.905 0.424 
Dab9-NH···O3-P 2.825 0.452 
Dab8-NH···O3-HM4 3.028 0.773 
Dab9-NH···O1A-KdoII 3.024 0.846 
Ala8-PmB3    
Dab9-NH···O3-P 2.799 0.954 
   
Ala 9-PmB3    
Dab1-NH···O4-P 2.746 0.934 
Dab8-NH···O1-HM2 2.888 0.907 
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probabilities) are represented, Dab1, Dab8 and Dab9 
amino acid residues of PmB3 form rather strong H-bonds 
(average N···O distance was less 0.3 nm). Amongst them, 
Н-bonds formed by residues Dab9 (with 1-phosphate and 
KdoII) and Dab8 (with fatty acid chain HM4) were the 
most stable in the course of MD simulations. Ala-
mutations of these residues maximally destabilize PmB3-
LPS complex: the values of binding energy for these 
mutants showed increase and large-amplitude irregular 
fluctuations (fig. 5).  
 
Conclusions 
 The structural and energetic aspects of PmB3-LPS 
binding have been studied by alanine scanning and 
molecular dynamics simulations. Ala-mutations of 
polymyxin’s residues Dab1, Dab3, Dab5, Dab8 and Dab9 
in the PmB3-LPS complex caused sustained structural 
changes which resulted in the notable loss in stability of 
LPS complexes with Ala-mutants of PmB3. Hydrogen 
bonding of polymyxin B with the lipopolysaccharide is an 
important factor of the stability of PmB3-LPS complex. 
The mutations disturb the characteristic hydrogen-bond 
network of PmB3-LPS complex. Ala-mutations of Dab1, 
Dab8 and Dab9 amino acid residues of PmB3 destabilized 
PmB3-LPS complex to a greater extent: the values of 
binding energy for these mutants showed increase and 
large-amplitude irregular fluctuations.  
 Detailed knowledge of the peculiarities of 
molecular interactions of polymyxins with its primary 
target on the outer membrane of Gram-negative bacteria is 
a prerequisite of a purposeful design of novel polymyxin-
like lipopeptides.   
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MOLECULAR DYNAMICS STUDY OF 
INTERACTIONS OF POLYMYXIN B3 AND ITS 
ALA-MUTANTS WITH LIPOPOLYSACCHARIDE  
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Introduction. Emergence of nosocomial bacterial 
pathogens (especially Gram-negative bacteria) with 
multiple resistance against almost all available antibiotics 
is a growing medical problem. No novel drugs targeting 
multidrug-resistant Gram-negative bacteria have been 
developed in recent years. In this context, there has been 
greatly renewed interest to cyclic lipodecapeptides 
polymyxins. Polymyxins exhibit rapid bactericidal 
activity, they are specific and highly potent against Gram-
negative bacteria, but have potential nephrotoxic side 
effects. So polymyxins are attractive lead compounds to 
develop analogues with improved microbiological, 
pharmacological and toxicological properties. A detailed 
knowledge of the molecular mechanisms of polymyxin 
interactions with its cell targets is a prerequisite for the 
purposeful improvement of its therapeutic properties. The 
primary cell target of a polymyxin is a lipopolysaccharide 
(LPS) in the outer membrane of Gram-negative bacteria. 
The binding site of polymyxin on LPS has been supposed 
to be Kdo2-lipid A fragment. Methods. For all molecular 
modeling and molecular dynamics simulation 
experiments the YASARA suite of programs was used. 
Complex of antimicrobial peptide polymyxin В3 (PmB3) 
with Kdo2-lipid A portion of  E. coli lipopolysaccharide 
was constructed by rigid docking with flexible side chains 
of the peptide. By alanine scanning of polymyxin В3 
bound to LPS followed by simulated annealing 
minimization of the complexes in explicit water 
environment, the molecular aspects of PmB3-LPS binding 
have been studied by 20 ns molecular dynamics 
simulations at 298 K and pH 7.0. The AMBER03 force 
field was used with a 1.05 nm force cutoff. To treat long 
range electrostatic interactions the Particle Mesh Ewald 
algorithm was used. Results. Ala-mutations of 
polymyxin’s residues Dab1, Dab3, Dab5, Dab8 and Dab9 
in the PmB3-LPS complex caused sustained structural 
changes resulting in the notable loss in stability of LPS 
complexes with Ala-mutants of PmB3. The mutations 
disturbed the characteristic hydrogen-bond network of 
PmB3-LPS complex. Ala-mutations of Dab1, Dab8 and 
Dab9 amino acid residues of PmB3 destabilized PmB3-
LPS complex to a greater extent: the values of binding 
energy for these mutants showed increase and large-
amplitude irregular fluctuations.  
Conclusions. Hydrogen bonding of polymyxin B with the 
lipopolysaccharide is an important factor of the stability 
of PmB3-LPS complex. Detailed knowledge of the 
peculiarities of molecular interactions of polymyxins with 
its primary target on the outer membrane of Gram-
negative bacteria is a prerequisite of a purposeful design 
of novel polymyxin-like lipopeptides.   
Keywords: polymyxin, lipopolysaccharide, lipid A, 
docking, molecular modeling. 
 
 
 
 
